BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 13499148)

  • 1. Down-regulation of HER-2 expression in human breast cancer cell HBC-4 and ZR75-1 by nitrogen-mustard-N-oxide.
    Sai S; Furuya Y; Fujino Y; Kuroda Y
    Kobe J Med Sci; 2007; 53(4):135-42. PubMed ID: 17932452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of non-aqueous solvents in preparing solutions of some N-acetylsarcolysine peptides].
    Safonov VP; Lopatin PV; Litvinova TP
    Farmatsiia; 1973; 22(1):16-20. PubMed ID: 4704577
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the differential kinematics of degeneration from toxic effects in the animal organism, shown by the examples of bis-betachloraethyl and bis-betachloraethyl-N-oxide].
    NIEPER HA
    Agressologie; 1961; 2():243-8. PubMed ID: 13728987
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical trials of mechlorethamine-N-oxide in therapy of tumors].
    SELLEI C; ECKHARDT A
    Munch Med Wochenschr; 1958 May; 100(19):784-6. PubMed ID: 13565952
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthesis and in vitro evaluation of macromolecular antitumour derivatives based on phenylenediamine mustard.
    De Winne K; Seymour LW; Schacht EH
    Eur J Pharm Sci; 2005 Feb; 24(2-3):159-68. PubMed ID: 15661487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chlorine cleavage and efficacy of nitrogen mustard compounds].
    PREUSSMANN R
    Arzneimittelforschung; 1958 Jan; 8(1):9-10. PubMed ID: 13510144
    [No Abstract]   [Full Text] [Related]  

  • 7. [Results of treatment of malignant tumors with N-mustard gas-phosphamide ester (endoxan)].
    SCHWENKENBECHER W
    Ther Ggw; 1959 Jun; 98(6):285-7. PubMed ID: 13676100
    [No Abstract]   [Full Text] [Related]  

  • 8. [Splitting off of chlorine and activity of nitrogen mustards. II. A new mustard group, 2-amino-1, 3-dichloropropane and structurally related compounds].
    PREUSSMANN R
    Arzneimittelforschung; 1958 Oct; 8(10):638-43. PubMed ID: 13607287
    [No Abstract]   [Full Text] [Related]  

  • 9. [N,N-Bis-(2-chlorethyl)-sulfamic acid derivatives. 4. Chlorine cleavability and biological activity in N-lost compounds].
    PREUSSMANN R
    Arzneimittelforschung; 1962 Nov; 12():1119-23. PubMed ID: 13986088
    [No Abstract]   [Full Text] [Related]  

  • 10. Necrotizing uveitis incident to perfusion of intractraial malignancies with nitrogen mustard or related compounds.
    ANDERSON B; ANDERSON B
    Trans Am Ophthalmol Soc; 1960; 58():95-104. PubMed ID: 13683174
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of topical nitrogen mustard on wound healing.
    HARRIS FL; THOMAS CG
    Surg Gynecol Obstet; 1961 Jun; 112():684-8. PubMed ID: 13711724
    [No Abstract]   [Full Text] [Related]  

  • 12. Toxicity of nitrogen mustard in relation to operations.
    MORALES F; McDONALD GO
    Surg Forum; 1957; 8():173-7. PubMed ID: 13529577
    [No Abstract]   [Full Text] [Related]  

  • 13. CHLORAMBUCIL.
    J Am Med Assoc; 1958 Jan; 166(1):50-1. PubMed ID: 13491311
    [No Abstract]   [Full Text] [Related]  

  • 14. [Nitrogen in preparation of injection solutions].
    FORS M
    Sven Farm Tidskr; 1954 Aug; 58(24):573-8. PubMed ID: 13196029
    [No Abstract]   [Full Text] [Related]  

  • 15. [Degradation of nitrogen mustard N-oxide in aqueous solutions].
    ARNOLD H; BROCK N; HOHORST HJ
    Arzneimittelforschung; 1957 Dec; 7(12):735-9. PubMed ID: 13499148
    [No Abstract]   [Full Text] [Related]  

  • 16. [The anti-tumor activity of several N-acetyl-sarcolysin derivatives in the form of non-aqueous solutions].
    Lopatin PV; Safonov VP; Litvinova TP
    Farmakol Toksikol; 1973; 26(4):479-80. PubMed ID: 4789902
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experimental bases of cancer chemotherapy; biochemical, pharmacological and histopathological studies with nitrogen mustard N-oxide].
    BROCK N
    Arzneimittelforschung; 1957 Dec; 7(12):727-35. PubMed ID: 13499147
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.